Boehringer Ingelheim

Boehringer Ingelheim, founded in 1885 by Albert Boehringer, is a global, research-driven pharmaceutical company headquartered in Ingelheim am Rhein, Germany. The company has a long-standing commitment to innovation, providing high-quality healthcare solutions for both humans and animals. With more than 53,000 employees operating in approximately 130 markets worldwide, Boehringer Ingelheim aims to enhance the lives of patients by developing breakthrough medicines and treatments. The company focuses on various therapeutic areas, including respiratory diseases, cardiometabolic diseases, oncology, and more.

As one of the world's top 20 pharmaceutical companies, Boehringer Ingelheim prides itself on being a family-owned enterprise. Its commitment to research and development has resulted in substantial investments in innovative medical solutions and patients' needs. The firm’s philosophy is reflected in its motto, 'Value Through Innovation,' which encapsulates its focus on delivering medical advancements that positively impact global health. With a robust research and production network, Boehringer Ingelheim supports initiatives aimed at sustainability and social responsibility, reinforcing its reputation as a leader in the pharmaceutical industry.